Organogenesis ran a successful FDA approved phase 3 trial in the US, which is more than PAR has done.
research reports and media, page-4094
-
- There are more pages in this discussion • 304 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.0¢ | 22.5¢ | $11.49K | 50.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 150730 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 1077 | 1 |
View Market Depth
| Last trade - 11.16am 15/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |